Global Prevalence of Glaucoma and Projections of Glaucoma Burden through 2040 | 2014/11/01 | English | 3,836 |
Global Prevalence of Myopia and High Myopia and Temporal Trends from 2000 through 2050 | 2016/05/01 | English | 2,383 |
Intravitreal Aflibercept (VEGF Trap-Eye) in Wet Age-related Macular Degeneration | 2012/12/01 | English | 1,634 |
Ranibizumab and Bevacizumab for Treatment of Neovascular Age-related Macular Degeneration | 2012/07/01 | English | 1,232 |
Ranibizumab for Diabetic Macular Edema | 2012/04/01 | English | 1,100 |
Clinical Classification of Age-related Macular Degeneration | 2013/04/01 | English | 1,025 |
Randomized Trial Evaluating Ranibizumab Plus Prompt or Deferred Laser or Triamcinolone Plus Prompt Laser for Diabetic Macular Edema | 2010/06/01 | English | 915 |
The RESTORE Study | 2011/04/01 | English | 901 |
Ranibizumab versus Verteporfin Photodynamic Therapy for Neovascular Age-Related Macular Degeneration: Two-Year Results of the ANCHOR Study | 2009/01/01 | English | 898 |
Predictors of Long-term Progression in the Early Manifest Glaucoma Trial | 2007/11/01 | English | 876 |
Intravitreal Bevacizumab (Avastin) for Neovascular Age-Related Macular Degeneration | 2006/03/01 | English | 802 |
Uveal Melanoma: Trends in Incidence, Treatment, and Survival | 2011/09/01 | English | 772 |
Seven-Year Outcomes in Ranibizumab-Treated Patients in ANCHOR, MARINA, and HORIZON | 2013/11/01 | English | 733 |
Outdoor Activity Reduces the Prevalence of Myopia in Children | 2008/08/01 | English | 732 |
The International Vitreomacular Traction Study Group Classification of Vitreomacular Adhesion, Traction, and Macular Hole | 2013/12/01 | English | 727 |
Three-Year, Randomized, Sham-Controlled Trial of Dexamethasone Intravitreal Implant in Patients with Diabetic Macular Edema | 2014/10/01 | English | 717 |
Recommendations on Screening for Chloroquine and Hydroxychloroquine Retinopathy (2016 Revision) | 2016/06/01 | English | 701 |
The Prevalence of Retinal Vein Occlusion: Pooled Data from Population Studies from the United States, Europe, Asia, and Australia | 2010/02/01 | English | 675 |
Randomized, Sham-Controlled Trial of Dexamethasone Intravitreal Implant in Patients with Macular Edema Due to Retinal Vein Occlusion | 2010/06/01 | English | 674 |
Automated Identification of Diabetic Retinopathy Using Deep Learning | 2017/07/01 | English | 643 |
Global Prevalence of Diabetic Retinopathy and Projection of Burden through 2045 | 2021/11/01 | English | 641 |
Survey of 1264 patients with orbital tumors and simulating lesions | 2004/05/01 | English | 616 |
Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema | 2016/06/01 | English | 610 |
Long-term Outcomes of Ranibizumab Therapy for Diabetic Macular Edema: The 36-Month Results from Two Phase III Trials | 2013/10/01 | English | 596 |
Intravitreal Aflibercept Injection for Neovascular Age-related Macular Degeneration | 2014/01/01 | English | 591 |
Ranibizumab for Macular Edema following Branch Retinal Vein Occlusion | 2010/06/01 | English | 580 |
Ranibizumab for Macular Edema following Central Retinal Vein Occlusion | 2010/06/01 | English | 579 |
Proposed Lexicon for Anatomic Landmarks in Normal Posterior Segment Spectral-Domain Optical Coherence Tomography | 2014/08/01 | English | 562 |
Intravitreal Aflibercept for Diabetic Macular Edema | 2014/11/01 | English | 557 |
Ranibizumab versus Bevacizumab to Treat Neovascular Age-related Macular Degeneration | 2012/07/01 | English | 556 |